[On combined therapy of hypertension and heart insufficiency. Advantages and disadvantages].
D001145:Arrhythmias, Cardiac / Q000188:drug therapy; D002752:Chlorthalidone / Q000627:therapeutic use*; D004074:Digitoxin / Q000627:therapeutic use; D004357:Drug Synergism; D006334:Heart Function Tests; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D007008:Hypokalemia; D008750:Methyldopa / Q000627:therapeutic use; D009203:Myocardial Infarction / Q000188:drug therapy; D011802:Quinidine / Q000627:therapeutic use; D012110:Reserpine / Q000627:therapeutic use*
D008750:Methyldopa; D012110:Reserpine; D004074:Digitoxin; D011802:Quinidine; D002752:Chlorthalidone
Uber Kombinationstherapie bei Hypertension und Herzinsuffizienz. Vorteile und Nachteile.